Literature DB >> 19927007

The prevalence and causes of visual loss among HIV-infected individuals in Uganda.

Juliet Otiti-Sengeri1, Robert Colebunders, John H Kempen, Allan Ronald, Merle Sande, Elly Katabira.   

Abstract

AIM: To determine the prevalence of loss of visual acuity and to describe the ocular diseases associated with vision loss among HIV-infected individuals in Uganda.
Methods: One thousand two hundred twelve HIV-positive individuals aged 18 years or older attending an HIV treatment site in Kampala,Uganda, were consecutively screened for loss of visual acuity using a Snellen chart. Those found to have a visual acuity of 6/9 or less in 1 or both eyes had a detailed ocular diagnostic evaluation.
Results: One hundred thirty-six patients [11.2%; 95% confidence interval (CI): 9.49–13.13] had a visual acuity of 6/9 or less in at least 1 eye, with 74 (6.1%; 95% CI: 8.54–12.21) having bilaterally reduced presenting visual acuity. Eighty-eight (7.3%; 95% CI: 8.57–12.28)had a visual acuity of 6/18 or worse in at least 1 eye. Ocular diseases associated with reduced vision included cataract 16 (11.8%), optic nerve disease 20 (14.7%), refractive errors 35 (24.3%), and uveitis 44 (32.3%). Other diagnoses observed included diabetic retinopathy,maculopathies, corneal scars, glaucoma, and squamous cell carcinoma of the conjunctiva.Conclusions: Visual impairment and ocular disease affect a large proportion of HIV-infected individuals presenting for HIV care in Uganda. Most causes of vision loss were treatable or could have been prevented with appropriate ophthalmic and medical care.

Entities:  

Mesh:

Year:  2010        PMID: 19927007     DOI: 10.1097/QAI.0b013e3181c313f0

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  6 in total

1.  Cytomegalovirus retinitis and the acquired immunodeficiency syndrome--bench to bedside: LXVII Edward Jackson Memorial Lecture.

Authors:  Douglas A Jabs
Journal:  Am J Ophthalmol       Date:  2010-12-18       Impact factor: 5.258

2.  CD4 T-cell activation and reduced regulatory T-cell populations are associated with early development of cataracts among HIV-infected adults in Uganda.

Authors:  Damalie Nakanjako; Juliet Otiti-Sengeri; Isaac Ssewanyana; Rose Nabatanzi; Lois Bayigga; Samuel Kirimunda; Moses Joloba; Yukari C Manabe; Andrew Kambugu; Robert Colebunders; Harriet Mayanja-Kizza
Journal:  Immunol Lett       Date:  2014-04-28       Impact factor: 3.685

3.  Predictors of HIV/AIDS Related Ocular Manifestations among HIV/AIDS Patients in Felege Hiwot Referral Hospital, Northwest Ethiopia.

Authors:  Guadie Sharew; Muluken Azage
Journal:  J Ophthalmol       Date:  2015-04-27       Impact factor: 1.909

4.  Elevated inflammatory cytokines in aqueous cytokine profile in HIV-1 infected patients with cataracts in Uganda.

Authors:  Juliet Otiti-Sengeri; Robert Colebunders; Steven J Reynolds; Musa Muwonge; Getrude Nakigozi; Valerian Kiggundu; Fred Nalugoda; Damalie Nakanjako
Journal:  BMC Ophthalmol       Date:  2018-01-19       Impact factor: 2.209

5.  Magnitude of visual impairment and associated factors among patients attending ophthalmic clinics of Debre Markos referral hospital, north West Ethiopia.

Authors:  Haimanot Abebe; Fasil Wagnew; Haymanot Zeleke; Bitew Tefera; Shegaw Tesfa; Tamene Fetene
Journal:  BMC Ophthalmol       Date:  2021-02-19       Impact factor: 2.209

6.  Evaluation of a low-resource screening strategy for ophthalmic pathologies and associated neurological morbidity in an older Tanzanian HIV-positive population.

Authors:  Grace George; Declan C Murphy; H D Jeffry Hogg; Japhet Bright Boniface; Sarah Urasa; Justus Rwiza; Livin Uwemeye; Clare Bristow; Grace Hillsmith; Emma Rainey; Richard Walker; William K Gray; Stella Maria-Paddick
Journal:  Sci Rep       Date:  2022-01-26       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.